Regulus Therapeutics (NASDAQ: RGLS) announced that it has commenced an underwritten public offering, subject to market and other conditions, to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE